📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

CRLF3 plays a key role in the final stage of platelet genesis and is a potential therapeutic target for thrombocythemia. (2022)

First Author: Bennett C

Attributed to: The Pluripotent Stem Cells and Engineered Cell (PSEC) Hub funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1182/blood.2021013113

PubMed Identifier: 35051265

Publication URI: http://europepmc.org/abstract/MED/35051265

Type: Journal Article/Review

Volume: 139

Parent Publication: Blood

Issue: 14

ISSN: 0006-4971